Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10035843 RSV-specific binding molecule

Patent 10035843 was granted and assigned to Medimmune Limited on July, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
February 12, 2016
0
Date of Patent
July 31, 2018
0
Patent Application Number
15042656
0
Patent Citations Received
‌
US Patent 12024553 Dosage regimens for and compositions including anti-RSV antibodies
0
‌
US Patent 10689437 RSV-specific antibodies and functional parts thereof
0
‌
US Patent 10723786 RSV-specific binding molecule
0
‌
US Patent 10774133 Anti-RSV monoclonal antibody formulation
‌
US Patent 11286294 Anti-RSV monoclonal antibody formulation
‌
US Patent 11661449 RSV-specific antibodies and functional parts thereof
0
‌
US Patent 11667698 Anti-RSV monoclonal antibody formulation
0
Patent Inventor Names
Tim Beaumont
0
Adrianus Q. Bakker
0
Etsuko Yasuda
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10035843
0
Patent Primary Examiner
‌
Stacy B. Chen
0

Find more entities like US Patent 10035843 RSV-specific binding molecule

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.